Skip to main content
Download PDF

Mobility-related brain regions linking carotid intima-media thickness to specific gait performances in old age

BMC Geriatrics volume 24, Article number: 303 (2024) Cite this article

Abstract

Background

Gait disturbance is common in older adults with vascular diseases. However, how carotid atherosclerosis affects gait remains poorly understood. The objectives were to investigate the associations between carotid intima-media thickness and specific gait performances and explore the potential role of brain structure in mediating these associations.

Methods

A cross-sectional analysis of data from the Taizhou Imaging Study was conducted, including 707 individuals who underwent both gait and carotid ultrasound examinations. Gait assessments include the Timed-Up-and-Go test, the Tinetti test, and quantitative gait assessment using a wearable device. Quantitative parameters were summarized into independent gait domains with factor analysis. Magnetic resonance images were obtained on a 3.0-Tesla scanner, and the volumes of fifteen brain regions related to motor function (primary motor, sensorimotor), visuospatial attention (inferior posterior parietal lobules, superior posterior parietal lobules), executive control function (dorsolateral prefrontal cortex, anterior cingulate), memory (hippocampus, entorhinal cortex), motor imagery (precuneus, parahippocampus, posterior cingulated cortex), and balance (basal ganglia: pallidum, putamen, caudate, thalamus) were computed using FreeSurfer and the Desikan-Killiany atlas. Mediation analysis was conducted with carotid intima-media thickness as the predictor and mobility-related brain regions as mediators.

Results

Carotid intima-media thickness was found to be associated with the Timed-Up-and-Go performance (β = 0.129, p = 0.010) as well as gait performances related to pace (β=-0.213, p < 0.001) and symmetry (β = 0.096, p = 0.045). Besides, gait performances were correlated with mobility-related brain regions responsible for motor, visuospatial attention, executive control, memory, and balance (all FDR < 0.05). Notably, significant regions differed depending on the gait outcomes measured. The primary motor (41.9%), sensorimotor (29.3%), visuospatial attention (inferior posterior parietal lobules, superior posterior parietal lobules) (13.8%), entorhinal cortex (36.4%), and motor imagery (precuneus, parahippocampus, posterior cingulated cortex) (27.3%) mediated the association between increased carotid intima-media thickness and poorer Timed-Up-and-Go performance. For the pace domain, the primary motor (37.5%), sensorimotor (25.8%), visuospatial attention (12.3%), entorhinal cortex (20.7%), motor imagery (24.9%), and balance (basal ganglia: pallidum, putamen, caudate, thalamus) (11.6%) acted as mediators.

Conclusions

Carotid intima-media thickness is associated with gait performances, and mobility-related brain volume mediates these associations. Moreover, the distribution of brain regions regulating mobility varies in the different gait domains. Our study adds value in exploring the underlying mechanisms of gait disturbance in the aging population.

Peer Review reports

Introduction

Gait disturbance is a prevalent chronic disorder among community-dwelling older adults, leading to an increased risk of falls, morbidity, and mortality [1,2,3]. Previous studies have shown that an increased cardiovascular risk is associated with impaired gait function, specifically decreased gait speed [4, 5]. Carotid atherosclerosis, primarily measured by carotid intima-media thickness (IMT), is associated with a higher risk of gait disorders, such as decreased walking speed and impaired balance ability [6,7,8]. This association between cardiovascular health and gait may be attributed to neurological abnormalities. According to the heart-brain axis, cardiovascular diseases (CVDs) could impair cerebral microvascular function [9]. For example, functional degeneration and structural changes in the carotid arteries profoundly affect intracranial blood vessels, resulting in brain structural changes such as white matter lesions [10] and brain atrophy [11, 12]. These changes in white and gray matter [13, 14], particularly brain volume [15,16,17], have been associated with gait disorders. Additionally, volume loss in brain regions responsible for mobility exhibits varying associations with poorer gait performances [18, 19], which might be attributed to low perfusion in different regions responsible for specific aspects of gait.

Nevertheless, few studies focus on the mechanisms through which carotid atherosclerosis impacts gait, and it remains unclear whether brain structure plays a vital role. Notably, previous studies that investigated the association between carotid atherosclerosis and gait have commonly used individual indicators or clinical rating scales to measure gait. However, in terms of specificity and sensitivity, sensor-based measurement techniques outperformed traditional methods. They can help obtain vast amounts of quantitative gait data in different dimensions and unveil gait problems in different domains [20, 21]. In this study, we used similar techniques to capture specific gait patterns.

Therefore, further understanding of how carotid atherosclerosis affects gait could help develop interventions to improve gait performances in the aging population. With objective quantitative gait analysis, this population-based study examined the associations of carotid IMT and plaque with specific gait performances. We also investigated whether mobility-related brain regions could mediate this relationship. We hypothesize that certain mobility-related brain regions may mediate the association between carotid indicators and specific gait performances.

Methods

Study design and participants

We conducted a cross-sectional study based on the Taizhou Imaging Study (TIS), an ongoing community-based cohort study. The inclusion and exclusion criteria for the baseline population have been described in detail previously [22]. Among the 904 individuals included in TIS, 741 participants underwent gait analysis. After excluding individuals with incomplete gait data, current use of mobility aids, incomplete carotid ultrasound examination, and incomplete magnetic resonance imaging (MRI) data, 707 individuals were included in the current analysis (Fig. S1). Ethical approval for the TIS was obtained from the Ethics Committee of the School of Life Sciences, Fudan University, and Fudan University Taizhou Institute of Health Sciences (Institutional Review Board approval numbers: 496 and B017, respectively). Written informed consent was obtained from all participants prior to data and biospecimen collection.

Measurement of gait

Gait assessment involved both clinical rating scales and quantitative gait assessment. The clinical rating scales assessment consisted of two commonly used tests: the Timed-Up-and-Go (TUG) test [23] and the Tinetti test [24]. The TUG test evaluates basic mobility and balance abilities by measuring the time it takes for an individual to complete a set of subtasks, such as standing up from a chair, walking 3 m, and turning around. On the other hand, the Tinetti test is a questionnaire that comprises 17 items in two subscales, with nine items assessing balance and eight items evaluating gait. Each item is scored 0–1 or 0–2, where a score of 0 represents the poorest performance. The total score of the Tinetti test ranges from 0 to 28. These standardized tests are widely utilized to assess the mobility and functional capacities of individuals in a clinical setting.

The quantitative gait data was collected through an insole-style wearable gait tracking device (Senno gait, Sennotech Co. Ltd., China). Participants were instructed to start from a designated point and walk a distance of 10 m in a straight line. They were then required to return along the same path to the starting point. During the whole process, participants were asked to walk at a comfortable and self-selected pace. The gait tracking device recorded and analyzed various gait parameters for each stride, excluding the turning strides. The quantitative gait parameters measured included stride time, stance time, swing time, stance time percentage of the gait cycle (%GC) symmetry, swing time (%GC) symmetry, stride time symmetry, stride time coefficient of variation (CV), stance time CV, swing time CV, heel strike angle, stride length, maximum swing velocity, gait velocity, stance time (%GC), and double support time (%GC). Considering that these spatiotemporal gait parameters are highly correlated, we subsequently summarized them into independent gait domains by factor analysis. We provide the definitions of each gait parameter and the domains they reflected a priori and indicate the direction in which a parameter is considered “poorer” (Table S1). According to previous studies, the impaired TUG test was defined as the duration of the TUG test > 12 s [25], and the impaired gait velocity was defined as gait velocity < 1 m/s [26]. The impaired gait group was defined by gait velocity < 1.0 m/s or TUG test duration > 12 s.

Measurement of carotid IMT and plaque

Carotid ultrasound examinations were conducted using the Philips iE33 Ultrasound System. Participants were positioned in a supine position to ensure the neck area was fully exposed for measurement. The optimal segment for measurement was identified as 10 mm proximal and distal to the carotid bulb, with the measurement taken on the distal walls. Bilateral common and internal carotid IMT measurements were recorded for each subject, and the maximum value from the four sites was used for analysis [27]. Carotid plaque was defined based on one of the three conditions: a focal protrusion in the vascular lumen exceeding 0.5 mm, a thickness 50% greater than the surrounding IMT, or an IMT exceeding 1.5 mm [28]. The ultrasound examinations were performed by the same technician using the same instrument, and computer software was used to collect the relevant features, ensuring completion of the examination within three cardiac cycles.

MRI acquisition and measurement

All participants underwent MRI scans using a 3.0T scanner (Magnetom Verio Tim scanner; Siemens, Erlangen, Germany) at Taizhou People’s Hospital. The detailed protocol and sequence parameters for MRI have been previously reported [29]. This study used volumetric measures of specific brain regions associated with mobility as regions of interest for analysis. Fifteen brain regions were selected a priori, including motor function (primary motor, sensorimotor), visuospatial attention (inferior posterior parietal lobules, superior posterior parietal lobules), executive control function (dorsolateral prefrontal cortex, anterior cingulate), memory (hippocampus, entorhinal cortex), motor imagery (precuneus, parahippocampus, posterior cingulated cortex), and balance (basal ganglia: pallidum, putamen, caudate, thalamus), based on previous studies [18, 19]. FreeSurfer software (v6.0.0) was used to extract the volume data of functional brain regions from structural T1 images, utilizing the Desikan-Killiany atlas [30]. All brain region volume was standardized using z-scores for analysis.

Co-variables

Demographic and lifestyle characteristics data were collected using a comprehensive questionnaire, which included information on age, sex, smoking habits, alcohol consumption, and physical activity. Physical examinations and diagnoses conducted by physicians obtained additional data on height and weight, and the body mass index (BMI) information was calculated as mass in kilograms divided by height in meters squared. Blood pressure was measured in person by experienced technicians at the Taizhou People’s Hospital, and morning fasting blood samples were collected by a certified nurse and processed using standard protocols [22]. Medical history, including hypertension, diabetes, and hyperlipidemia, were defined as the following criteria. Hypertension was defined as a blood pressure greater than 140/90 mmHg, a self-reported history, or current use of antihypertensive drugs. Diabetes was defined as fasting blood glucose greater than 7.0 mmol/L, a self-reported history, or current use of anti-diabetic drugs. Hyperlipidemia was defined as total cholesterol greater than 5.2 mmol/L, triglyceride greater than 1.7 mmol/L, a self-reported history, or current use of antihyperlipidemic drugs. Current smoking was defined by the frequency of smoking in the past six months and categorized into “never” and ≥ one cigarette every 1–3 days. Current alcohol drinking was defined by the frequency in the past six months and categorized into “never” and ≥ three times per week. Physical activity was defined by the frequency of exercise during the past year, including “never”, “1–3 times per month”, “1–2 times per week”, “3–5 times per week”, and “6–7 times per month”. We categorized physical activity into “no exercise” and “exercise” by classifying “1–3 times per month”, “1–2 times per week”, “3–5 times per week”, and “6–7 times per month” into the “exercise” group and incorporated it as a binary variable in our models. The analysis considered these covariates to account for their potential influence on the relationships among carotid IMT, brain regions, and gait performances.

Statistical analysis

Description analysis

Continuous variables were reported as mean (standard deviation, SD), and categorical variables were presented as frequencies (%). The normality of continuous variables was assessed using the Shapiro-Wilk test. Since the data presented skewness, logarithmic transformation was applied to the TUG, Tinetti, and gait variables related to symmetry, and square root transformation was applied to the gait variables related to variability. Group differences were examined using the following statistical tests: the two-sample t-test or Wilcoxon rank sum test was used for continuous variables, and Pearson’s chi-squared test or Fisher’s exact test was applied for categorical variables.

Factor analysis of quantitative gait parameters

A factor analysis (varimax rotation, eigenvalue 1.0) was employed for the 15 quantitative gait parameters [30]. The original variables in the rhythm, symmetry, variability, and phase domains were inverted to represent poorer gait performances with lower values. Variables with correlation loadings greater than 0.5 were considered significantly correlated with the corresponding factors. Gait parameters were then categorized into independent gait domains based on the extracted factors, which were standardized and expressed as z-scores for further analysis.

Association analysis

General linear models were employed to investigate the associations among carotid indicators, gait performances (clinical rating scale performances and gait domains), and mobility-related brain regions. The regression analysis was fitted in two models: Model 1 was adjusted for age, sex, and standardized total intracranial volume (included in the analysis of brain volume); Model 2 was further adjusted for BMI, hypertension, diabetes, hyperlipidemia, smoking, drinking, and physical activity. The dependent and independent variables were standardized before regression analysis, by subtracting the mean and dividing by the SD for each value of each variable. The results of regression were shown as standardized beta coefficients. Multiple testing problem was corrected by the false discovery rate (FDR) method.

Mediation analysis

Mediation analysis was performed to investigate whether differences in brain region volume mediated the associations between carotid IMT and gait performances. The brain regions that showed statistically significant associations with both carotid IMT and gait performances were included in the analysis. The mediation analysis used the R package “mediation” with 1,000 repetitions to estimate the direct effect (path c’), the mediation effect, and the total effect (path c). Using the R package “medsens”, we performed the sensitivity analysis of mediation to explore whether the presence of unmeasured confounders would violate the assumption and to identify the robustness of the results [31]. The results were presented as ρ, a Pearson correlation between the error terms of the regression models for the mediator and outcome and the product of the coefficient of determination of the two models. The threshold of statistical significance was set at corrected p < 0.05. Statistical analyses were performed using R software (Version 4.2.2).

Results

Characteristics of the study population

Demographic, cardiovascular risk factors, neuroimaging, and representative gait characteristics of the 707 involved participants are presented in Table 1. The mean age of the participants was 59.8 years, with females accounting for 57.7%. All included subjects were divided into two groups based on gait characteristics. The impaired gait group, comprising 27.7% of the sample (N = 196), tended to be older and female. They also exhibited higher BMI, smaller gray matter volume, and a higher prevalence of hypertension.

Table 1  Characteristics of study participants
Full size table

Association analysis of carotid IMT and plaque with gait performances

As shown in Table 2, per 1-standard deviation (SD) increase in the carotid IMT was significantly associated with poorer TUG performance (β = 0.153, p < 0.001). This association remained robust after adjusting for cardiovascular risk factors (β = 0.129, p = 0.010).

Table 2 Associations of IMT and plaque with clinical rating scale performances
Full size table

We summarized the quantitative gait parameters into five independent domains based on factor analysis. The five summarized factors accounted for 89.51% of the total variance (Table S2). These factors were categorized as follows based on previous research [20, 32]: rhythm domain (stride time, stance time, swing time), phase domain (double support time percentage of the gait cycle, stance time percentage of the gait cycle), symmetry domain (stance time percentage of the gait cycle symmetry, swing time percentage of the gait cycle symmetry, stride time symmetry), variability domain (stance time coefficient of variation, swing time coefficient of variation, stride time coefficient of variation), and pace domain (stride length, maximum swing velocity, heel strike angle, gait velocity).

The associations of carotid IMT and plaque with gait domains were further examined (Table 3). After full adjustment, carotid IMT was found to be associated with specific gait domains, including symmetry (β = 0.096, p = 0.045) and pace (β = -0.213, p < 0.001). However, no statistically significant association was observed between carotid plaque and any gait characteristics.

Table 3 Associations of gait domains with IMT and plaque
Full size table

Association analysis of carotid IMT and gait performances with mobility-related brain regions

Figure 1A and Table S3 illustrate that the significant regions associated with carotid IMT encompassed most mobility-related regions. However, the executive control function and hippocampus did not show significant associations (β = -0.072 and 0.058, respectively; both FDR > 0.05).

Fig. 1
figure 1

Associations of IMT and IMT-related gait performances with mobility-related brain regions. (Standardized regression coefficients (β) and significance from linear regression models are presented. All models were adjusted for sex, age, standardized total intracranial volume, BMI, hypertension, diabetes, hyperlipidemia, smoking, alcohol consumption, and physical activity. The significance threshold was set at *p < 0.05, **p < 0.01, and ***p < 0.001 after correcting for the false discovery rate.)

Full size image

After full adjustment, poorer TUG performance was significantly associated with smaller volume in the primary motor (β = -0.179, FDR < 0.001), sensorimotor (β = -0.162, FDR < 0.001), visuospatial attention (β = -0.121, FDR = 0.007), entorhinal cortex (β = -0.155, FDR < 0.001), and motor imagery (β = -0.171, FDR < 0.001) regions (Fig. 1B and Table S4). Additionally, the pace domain exhibited positive correlations with the volume of the primary motor (β = 0.286, FDR < 0.001), sensorimotor (β = 0.245, FDR < 0.001), visuospatial attention (β = 0.188, FDR < 0.001), executive control (β = 0.161, FDR = 0.001), entorhinal cortex (β = 0.176, FDR < 0.001), motor imagery (β = 0.277, FDR < 0.001), and basal ganglia (β = 0.203, FDR < 0.001) regions (Fig. 1C and Table S4). However, no statistically significant association was observed between mobility-related brain volume and the symmetry domain (Fig. 1D and Table S4). Except for the two domains related to increased IMT, we also found the variability domain was associated with the volume of the primary motor (β = 0.129, FDR = 0.007), sensorimotor (β = 0.148, FDR = 0.004), and entorhinal cortex (β = 0.103, FDR = 0.026) (Table S5).

The mediation effect of mobility-related brain regions in the associations between carotid IMT and gait performances

We investigated whether mobility-related brain regions mediate the relationships between carotid IMT and gait performances using mediation analysis. As presented in Fig. 2A and Table S6, we found areas associated with primary motor (41.9%, pmediation=0.002), sensorimotor (29.3%, pmediation=0.010), visuospatial attention (13.8%, pmediation=0.022), entorhinal cortex (36.4%, pmediation=0.006), and motor imagery (27.3%, pmediation=0.002) mediated the relationship between carotid IMT and TUG performance. Additionally, the primary motor (37.5%, pmediation<0.001), sensorimotor (25.8%, pmediation<0.001), visuospatial attention (12.3%, pmediation=0.004), entorhinal cortex (20.7%, pmediation<0.001), motor imagery (24.9%, pmediation<0.001), and basal ganglia (11.6%, pmediation=0.006) mediated the association between carotid IMT and the pace domain (Fig. 2B and Table S6).

Fig. 2
figure 2

Mediation effects of mobility-related brain regions in the associations between IMT and specific gait performances. (All models were adjusted for sex, age, BMI, hypertension, diabetes, hyperlipidemia, smoking, alcohol consumption, and physical activity. Standardized total intracranial volume was added when brain volume was included. CI, confidence interval.)

Full size image

Sensitivity analysis

We conducted sensitivity analyses to assess the potential impact of unmeasured confounding in the mediation analysis. The results, displayed in Table S7, indicated that the estimated indirect effects were relatively robust to the presence of unmeasured confounders, as indicated by the sensitivity parameter (ρ). Considering the effect of different exercise frequencies, we repeated the analysis by using physical activity as an ordinal variable instead of a binary one, where no significantly different results were found (Table S8–S14).

Discussion

This study investigated potential mechanisms underlying the relationships among increased carotid intima-media thickness, mobility-related brain volume, and gait abnormalities in community-dwelling Chinese older adults. Our major findings are as follows. First, increased carotid IMT was independently associated with poorer gait performances, whereas carotid plaque did not show any significant associations with gait disturbance. Second, poorer gait performances were linked to smaller volumes of mobility-related brain regions, and the significant regions differed depending on the gait outcomes measured. Finally, the volume of mobility-related brain regions mediated the relationship between increased carotid IMT and gait disturbance.

In alignment with our findings, previous studies have consistently shown that carotid IMT affects gait performance [6,7,8]. Notably, we found that carotid IMT was positively correlated with the symmetry domain. It may be attributed to the biological mechanism of cerebrovascular disease, which can lead to diffuse lesions affecting bilateral neural pathways and then increase gait symmetry [33]. The association between carotid plaque and poor gait performance has been reported [6, 34]. However, our study did not find significant associations between carotid plaque and other gait domains, such as rhythm and phase. These discrepancies might be due to differences in the study population and gait measurements. Our study involved relatively younger and healthier individuals compared to the previous research. In addition to the TUG test and Tinetti test, our research used more objective quantitative gait measures, whereas the other studies we compared used the 40-foot walking test, maximum walking speed, and the modified Tinetti scale alone.

The significant regions differed depending on the gait parameter measured, which may be due to impairment of the underlying circuits controlling pace, variability, and balance. For instance, it has been shown that slower gait speed is associated with selective volume of the motor cortex, parahippocampus, and dorsolateral prefrontal cortex, which play a vital role in motor, motor imagery, and executive control functions [18, 35]. Furthermore, higher step length variability was associated with the volume of the hippocampus, superior parietal lobe, and anterior cingulate gyrus, which are crucial for maintaining gait stability and consistency [36]. Additionally, the volume of the superior lobule and putamen, involved in visuospatial orientation and regulation, may lead to poorer balance control [35]. Interestingly, we found that brain regions affecting the variability domain differed from those affecting the pace domain, indicating that mobility-related brain regions control different gait domains [37]. The pace domain was associated with almost all mobility-related areas, suggesting that the excessively sensitive pace regulation might involve widespread gray matter networks. The variability domain was associated with the primary motor, sensorimotor cortex, and entorhinal cortex. The involvement of the entorhinal cortex is noteworthy as it is an early affected region in Alzheimer’s disease pathology [38], implying the importance of cognitive factors in influencing gait variability. However, our results focused on two specific gait domains, and further research is needed to explore whether the brain-gait association is indeed specific to these domains or extends to other domains of gait.

Our current investigation demonstrated that brain regions related to motor, visuospatial attention, memory, motor imagery, and balance mediate the relationships between carotid IMT and gait performances. Regretfully, research investigating the effects of brain structure on the association between atherosclerosis and gait remains limited. Nevertheless, some indirect studies shed light on the role of neural factors in this relationship. For example, gray matter atrophy, common in individuals with carotid atherosclerosis [12], has been reported to have detrimental effects on specific gait changes [14, 39]. The potential disturbance of local cerebral microcirculation of gray matter can help explain the findings in the current study. Of its high metabolic demand and great cerebral blood flow, the gray matter may be impacted by increased carotid IMT. Damage to essential fiber bundles and loops in these regions can impair gait-related functions.

Our study provides novel insights into the mediating effects of mobility-related brain regions on the relationships between carotid IMT and specific gait performances in old age. We employed a quantitative approach to measure gait function, which offers greater sensitivity than qualitative or semi-quantitative methods. We could conduct a focused analysis of specific gait patterns by categorizing highly correlated gait parameters into different domains. Moreover, we explored the combined effects of vascular factors and the nervous system on gait and identified potential mechanisms. However, our study has several limitations. First, it is challenging to establish a direct causative sequence as a cross-sectional study. Further investigation using longitudinal designs of TIS would be valuable in unraveling the causal relationships among carotid IMT, mobility-related brain regions, and gait performances. Second, musculoskeletal factors, such as muscle mass and strength, osteopenia, and osteoarthritis, were not taken into account. Including these factors in future studies would provide a more comprehensive understanding of gait. Third, our study only focused on the mediating role of gray matter volume between carotid IMT and gait. Considering the mediating role of white matter health in the relationship between CVDs and gait, future studies need to consider whether white matter integrity mediates the association between carotid atherosclerosis and gait performances. Finally, considering the structural and functional connectivity between brain regions, further analysis is warranted to reveal how the functional dynamics between these regions relate to carotid atherosclerosis and gait performances.

Conclusion

The present study indicates that increased carotid IMT is associated with the volume of mobility-related brain regions, leading to poor gait performances. And, different gait domains are affected by mobility-related brain regions responsible for specific functions. Our findings highlight the specific contribution of gray matter volume to gait disturbance associated with increased carotid IMT. However, larger population studies and longitudinal investigations are necessary to validate our findings further and elucidate the neural mechanisms underlying the association between carotid atherosclerosis and gait disturbance in more detail.

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

BMI:

Body mass index

CI:

Confidence interval

CV:

Coefficient of variation

CVDs:

Cardiovascular diseases

FDR:

False discovery rate

IMT:

Intima-media thickness

MRI:

Magnetic resonance imaging

SD:

Standard deviation

TIS:

Taizhou Imaging Study

TUG:

Timed-Up-and-Go

%GC:

Percentage of the gait cycle

References

  1. Mahlknecht P, Kiechl S, Bloem BR, Willeit J, Scherfler C, Gasperi A, Rungger G, Poewe W, Seppi K. Prevalence and burden of gait disorders in elderly men and women aged 60–97 years: a population-based study. PLoS ONE. 2013;8(7):e69627.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology. 2010;21(5):658–68.

    Article  PubMed  Google Scholar 

  3. Ye P, Er Y, Wang H, Fang L, Li B, Ivers R, Keay L, Duan L, Tian M. Burden of falls among people aged 60 years and older in mainland China, 1990–2019: findings from the global burden of Disease Study 2019. Lancet Public Health. 2021;6(12):e907–18.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Heiland EG, Qiu C, Wang R, Santoni G, Liang Y, Fratiglioni L, Welmer AK. Cardiovascular Risk Burden and Future Risk of walking speed limitation in older adults. J Am Geriatr Soc. 2017;65(11):2418–24.

    Article  PubMed  Google Scholar 

  5. Wang Z, Cui K, Song R, Li X, Qi X, Buchman AS, Bennett DA, Xu W. Influence of Cardiovascular Risk Burden on motor function among older adults: Mediating Role of Cardiovascular diseases Accumulation and Cognitive decline. Front Med (Lausanne). 2022;9:856260.

    Article  PubMed  Google Scholar 

  6. Elbaz A, Ripert M, Tavernier B, Février B, Zureik M, Gariépy J, Alpérovitch A, Tzourio C. Common carotid artery intima-media thickness, carotid plaques, and walking speed. Stroke. 2005;36(10):2198–202.

    Article  PubMed  Google Scholar 

  7. Hamer M, Kivimaki M, Lahiri A, Yerramasu A, Deanfield JE, Marmot MG, Steptoe A. Walking speed and subclinical atherosclerosis in healthy older adults: the Whitehall II study. Heart. 2010;96(5):380–4.

    Article  PubMed  Google Scholar 

  8. Bertoni AG, Whitt-Glover MC, Chung H, Le KY, Barr RG, Mahesh M, Jenny NS, Burke GL, Jacobs DR. The association between physical activity and subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2009;169(4):444–54.

    Article  PubMed  Google Scholar 

  9. Lutski M, Haratz S, Weinstein G, Goldbourt U, Tanne D. Impaired cerebral hemodynamics and Frailty in patients with Cardiovascular Disease. Journals Gerontol Ser Biol Sci Med Sci. 2018;73(12):1714–21.

    Article  CAS  Google Scholar 

  10. Jiang X, Lewis CE, Allen NB, Sidney S, Yaffe K. Premature Cardiovascular Disease and Brain Health in midlife: the CARDIA Study. Neurology. 2023;100(14):e1454–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Caughey MC, Qiao Y, Windham BG, Gottesman RF, Mosley TH, Wasserman BA. Carotid Intima-Media Thickness and Silent Brain infarctions in a Biracial Cohort: the atherosclerosis risk in communities (ARIC) Study. Am J Hypertens. 2018;31(8):869–75.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sabayan B, van Buchem MA, Sigurdsson S, Zhang Q, Meirelles O, Harris TB, Gudnason V, Arai AE, Launer LJ. Cardiac and carotid markers Link with accelerated brain atrophy: the AGES-Reykjavik Study (Age, Gene/Environment Susceptibility-Reykjavik). Arterioscler Thromb Vasc Biol. 2016;36(11):2246–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Jiang M, Wu S, Zhang Y, Li Y, Lin B, Pan Q, Tian S, Ni R, Liu Q, Zhu Y. Impact of White Matter Hyperintensity and Age on Gait parameters in patients with cerebral small Vessel Disease. J Am Med Dir Assoc. 2023;24(5):672–8.

    Article  PubMed  Google Scholar 

  14. Kim YJ, Kwon HK, Lee JM, Cho H, Kim HJ, Park HK, Jung NY, San Lee J, Lee J, Jang YK, et al. Gray and white matter changes linking cerebral small vessel disease to gait disturbances. Neurology. 2016;86(13):1199–207.

    Article  PubMed  Google Scholar 

  15. Jayakody O, Breslin M, Beare R, Blumen HM, Srikanth VK, Callisaya ML. Regional associations of cortical thickness with Gait variability-the Tasmanian Study of Cognition and Gait. The journals of gerontology Series A, Biological sciences and medical sciences 2020, 75(8):1537–44.

  16. Callisaya ML, Beare R, Phan TG, Blizzard L, Thrift AG, Chen J, Srikanth VK. Brain structural change and gait decline: a longitudinal population-based study. J Am Geriatr Soc. 2013;61(7):1074–9.

    Article  PubMed  Google Scholar 

  17. Lee S, Kim EY, Shin C. Longitudinal association between brain volume change and gait speed in a general population. Exp Gerontol. 2019;118:26–30.

    Article  PubMed  Google Scholar 

  18. DiSalvio NL, Rosano C, Aizenstein HJ, Redfern MS, Furman JM, Jennings JR, Whitney SL, Sparto PJ. Gray Matter regions Associated with Functional mobility in Community-Dwelling older adults. J Am Geriatr Soc. 2020;68(5):1023–8.

    Article  PubMed  Google Scholar 

  19. Rosano C, Bennett DA, Newman AB, Venkatraman V, Yaffe K, Harris T, Kritchevsky S, Aizenstein HJ. Patterns of focal gray matter atrophy are associated with bradykinesia and gait disturbances in older adults. Journals Gerontol Ser Biol Sci Med Sci. 2012;67(9):957–62.

    Article  Google Scholar 

  20. Pieruccini-Faria F, Black SE, Masellis M, Smith EE, Almeida QJ, Li KZH, Bherer L, Camicioli R, Montero-Odasso M. Gait variability across neurodegenerative and cognitive disorders: results from the Canadian Consortium of Neurodegeneration in Aging (CCNA) and the Gait and Brain Study. Alzheimer’s Dement J Alzheimer’s Assoc. 2021;17(8):1317–28.

    Article  Google Scholar 

  21. Darweesh SKL, Licher S, Wolters FJ, Koudstaal PJ, Ikram MK, Ikram MA. Quantitative gait, cognitive decline, and incident dementia: the Rotterdam Study. Alzheimer’s Dement J Alzheimer’s Assoc. 2019;15(10):1264–73.

    Article  Google Scholar 

  22. Jiang Y, Cui M, Tian W, Zhu S, Chen J, Suo C, Liu Z, Lu M, Xu K, Fan M, et al. Lifestyle, multi-omics features, and preclinical dementia among Chinese: the Taizhou Imaging Study. Alzheimer’s Dement J Alzheimer’s Assoc. 2021;17(1):18–28.

    Article  Google Scholar 

  23. Kear BM, Guck TP, McGaha AL. Timed up and go (TUG) test: normative reference values for Ages 20 to 59 years and relationships with Physical and Mental Health Risk factors. J Prim Care Community Health. 2017;8(1):9–13.

    Article  PubMed  Google Scholar 

  24. Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. Am J Med. 1986;80(3):429–34.

    Article  CAS  PubMed  Google Scholar 

  25. Bischoff HA, Stähelin HB, Monsch AU, Iversen MD, Weyh A, von Dechend M, Akos R, Conzelmann M, Dick W, Theiler R. Identifying a cut-off point for normal mobility: a comparison of the timed ‘up and go’ test in community-dwelling and institutionalised elderly women. Age Ageing. 2003;32(3):315–20.

    Article  PubMed  Google Scholar 

  26. Cesari M, Kritchevsky SB, Penninx BW, Nicklas BJ, Simonsick EM, Newman AB, Tylavsky FA, Brach JS, Satterfield S, Bauer DC, et al. Prognostic value of usual gait speed in well-functioning older people–results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005;53(10):1675–80.

    Article  PubMed  Google Scholar 

  27. Zhang K, Jiang Y, Wang Y, Suo C, Xu K, Zhu Z, Zhu C, Zhao G, Jin L, Ye W, et al. Associations of arterial stiffness and carotid atherosclerosis with cerebral small Vessel Disease in a Rural Community-based Population. J Atheroscler Thromb. 2020;27(9):922–33.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M et al. Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis: 2007, 23(1):75–80.

  29. Wang Y, Jiang Y, Suo C, Yuan Z, Xu K, Yang Q, Tang W, Zhang K, Zhu Z, Tian W, et al. Deep/mixed cerebral microbleeds are associated with cognitive dysfunction through thalamocortical connectivity disruption: the Taizhou Imaging Study. Neuroimage Clin. 2019;22:101749.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Wang Y, Jiang Y, Lu H, Tian W, Li P, Xu K, Fan M, Zhao X, Dong Q, Jin L, et al. Cross-sectional associations between cortical thickness and independent gait domains in older adults. J Am Geriatr Soc. 2022;70(9):2610–20.

    Article  PubMed  Google Scholar 

  31. Hicks R, Tingley D. Causal mediation analysis. Stata J. 2011;11(4):p605–619.

    Article  Google Scholar 

  32. Sedaghat S, Darweesh SKL, Verlinden VJA, van der Geest JN, Dehghan A, Franco OH, Hoorn EJ, Ikram MA. Kidney function, gait pattern and fall in the general population: a cohort study. Nephrol Dialysis Transplantation. 2018;33(12):2165–72.

    Article  CAS  Google Scholar 

  33. Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw FE. Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol. 2018;14(7):387–98.

    Article  PubMed  Google Scholar 

  34. El Khoudary SR, Chen HY, Barinas-Mitchell E, McClure C, Selzer F, Karvonen-Gutierrez C, Jackson EA, Ylitalo KR, Sternfeld B. Simple physical performance measures and vascular health in late midlife women: the study of women’s Health across the nation. Int J Cardiol. 2015;182:115–20.

    Article  PubMed  Google Scholar 

  35. Rosano C, Aizenstein HJ, Studenski S, Newman AB. A regions-of-interest volumetric analysis of mobility limitations in community-dwelling older adults. Journals Gerontol Ser Biol Sci Med Sci. 2007;62(9):1048–55.

    Article  Google Scholar 

  36. Rosso AL, Olson Hunt MJ, Yang M, Brach JS, Harris TB, Newman AB, Satterfield S, Studenski SA, Yaffe K, Aizenstein HJ, et al. Higher step length variability indicates lower gray matter integrity of selected regions in older adults. Gait Posture. 2014;40(1):225–30.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Verlinden VJ, van der Geest JN, Hofman A, Ikram MA. Cognition and gait show a distinct pattern of association in the general population. Alzheimer’s Dement J Alzheimer’s Assoc. 2014;10(3):328–35.

    Article  Google Scholar 

  38. Igarashi KM. Entorhinal cortex dysfunction in Alzheimer’s disease. Trends Neurosci. 2023;46(2):124–36.

    Article  CAS  PubMed  Google Scholar 

  39. Ogama N, Endo H, Satake S, Niida S, Arai H, Sakurai T. Impact of regional white matter hyperintensities on specific gait function in Alzheimer’s disease and mild cognitive impairment. J Cachexia Sarcopenia Muscle. 2021;12(6):2045–55.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We appreciate all the participants, staff, and graduate students of TIS for their crucial contributions.

Funding

This work was supported by the Science and Technology Innovation 2030 Major Projects (grant number 2022ZD0211600); National Key Research and Development program of China (grant number 2021YFC2500100); the Natural Science Foundation of Shanghai, China (grant numbers 23ZR1414000, 22ZR1405300); the Shanghai Rising-Star Program (grant number 22QA1404000); the National Natural Science Foundation of China (grant number 82304239); and Fudan School of Public Health-Jiading CDC key disciplines for the high-quality development of public health (grant number GWGZLXK-2023-02).

Author information

Authors and Affiliations

  1. School of Public Health, the Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China

    Xin Zhang, Chen Suo, Tiejun Zhang & Kelin Xu

  2. Fudan University Taizhou Institute of Health Sciences, Taizhou, Jiangsu, China

    Xin Zhang, Mei Cui, Yanfeng Jiang, Chen Suo, Tiejun Zhang, Kelin Xu, Yingzhe Wang & Xingdong Chen

  3. Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China

    Heyang Lu & Mei Cui

  4. Taixing Disease Control and Prevention Center, Taizhou, Jiangsu, China

    Min Fan

  5. Taizhou People’s Hospital Affiliated to Nantong University, Taizhou, Jiangsu, China

    Weizhong Tian

  6. State Key Laboratory of Genetic Engineering, Zhangjiang Fudan International Innovation Center, School of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, China

    Yanfeng Jiang, Yingzhe Wang & Xingdong Chen

  7. National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China

    Xingdong Chen

  8. Yiwu Research Institute of Fudan University, Yiwu, Zhejiang, China

    Xingdong Chen

Authors
  1. Xin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heyang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Weizhong Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mei Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yanfeng Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chen Suo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tiejun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kelin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yingzhe Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xingdong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XZ and KX: preparation of manuscript; HL, MF, WT, YJ, CS, and TZ: acquisition of subjects and/or data; XZ and YW: analysis and interpretation of data; KX, MC, YW, and XC: study concept and design. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Kelin Xu, Yingzhe Wang or Xingdong Chen.

Ethics declarations

Ethics approval and consent to participate

The studies involving human participants were reviewed and approved by the Ethics Committee of the School of Life Sciences, Fudan University, and Fudan University Taizhou Institute of Health Sciences (institutional review board approval number: 496 and B017, respectively). The patients/participants provided their written informed consent to participate in this study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Lu, H., Fan, M. et al. Mobility-related brain regions linking carotid intima-media thickness to specific gait performances in old age. BMC Geriatr 24, 303 (2024). https://doi.org/10.1186/s12877-024-04918-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12877-024-04918-1

Keywords

BMC Geriatrics

ISSN: 1471-2318

Contact us